The estimated Net Worth of Mischa Reis is at least $2.29 Milion dollars as of 18 March 2022. Mr. Reis owns over 10,092 units of Envista Corp stock worth over $730,631 and over the last 5 years he sold NVST stock worth over $1,560,434. In addition, he makes $0 as Senior Vice President - Strategy and Corporate Development at Envista Corp.
Sign up
Mr. Reis NVST stock SEC Form 4 insiders trading
Mischa has made over 10 trades of the Envista Corp stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 10,092 units of NVST stock worth $192,152 on 18 March 2022.
The largest trade he's ever made was selling 25,479 units of Envista Corp stock on 7 May 2021 worth over $1,168,977. On average, Mischa trades about 3,165 units every 38 days since 2019. As of 18 March 2022 he still owns at least 41,419 units of Envista Corp stock.
You can see the complete history of Mr. Reis stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mischa Reis biography
Mischa M. Reis serves as Senior Vice President - Strategy and Corporate Development of the Company since September 2019. Prior to that, Mr. Reis served as Vice President, Business Development & Strategy of Danaher’s Dental business since October 2012.
How old is Mischa Reis?
Mischa Reis is 48, he's been the Senior Vice President - Strategy and Corporate Development of Envista Corp since 2019. There are 16 older and 2 younger executives at Envista Corp. The oldest executive at Envista Holdings Corp is Amir Aghdaei, 62, who is the President, Chief Executive Officer, Director.
What's Mischa Reis's mailing address?
Mischa's mailing address filed with the SEC is C/O ENVISTA HOLDINGS CORPORATION, 200 S. KRAEMER BLVD., BLDG. E, BREA, CA, 92821.
Insiders trading at Envista Corp
Over the last 5 years, insiders at Envista Corp have traded over $35,099,063 worth of Envista Corp stock and bought 101,717 units worth $1,939,832 . The most active insiders traders include Corp /De/ Danaher, Vivek Jain oraz Wendy Carruthers. On average, Envista Corp executives and independent directors trade stock every 31 days with the average trade being worth of $320,413. The most recent stock trade was executed by Paul A Keel on 13 August 2024, trading 30,000 units of NVST stock currently worth $506,100.
What does Envista Corp do?
we know that dental professionals do more than create healthy, beautiful smiles—they create confidence. to achieve their goals, they need a champion. they need someone who will be there for them, side by side and end to end. at envista, we are uniquely positioned to be this champion. our differentiated combination of continuous improvement, a bias toward action and innovation, and a deep respect for the professionals we serve embolden us to champion dental professionals like no one else can. our comprehensive product portfolio covers an estimated 90% of dentists’ clinical needs for diagnosing, treating and preventing dental conditions as well as improving the aesthetics of the human smile. we believe true champions lift each other up, and we are looking for new champions to join our team. if you believe, champions do more than win, they stand for something bigger, you can build a meaningful career at envista. if you believe champions work to be their best, help others be theirs, sho
What does Envista Corp's logo look like?
Complete history of Mr. Reis stock trades at Envista Corp
Envista Corp executives and stock owners
Envista Corp executives and other stock owners filed with the SEC include:
-
Amir Aghdaei,
President, Chief Executive Officer, Director -
Amir Aghdaei,
Pres, CEO & Director -
Patrik Eriksson,
Senior Vice President -
Curt Bludworth,
Chief Human Resource Officer, Senior Vice President -
Howard Yu,
Chief Financial Officer, Senior Vice President -
Patrik Eriksson,
Sr. VP & Pres of Nobel Biocare -
Howard H. Yu,
Sr. VP & CFO -
Mark E. Nance,
Sr. VP, Gen. Counsel & Sec. -
Jean-Claude E. Kyrillos,
Sr. VP and Pres of Imaging & DTX -
Scott Huennekens,
Independent Chairman of the Board -
Christine Tsingos,
Independent Director -
Wendy Carruthers,
Independent Director -
Kieran Gallahue,
Independent Director -
Daniel Raskas,
Director -
John Bedford,
Vice President - Investor Relations -
Gayle Sheppard,
Independent Director -
Vivek Jain,
Independent Director -
Mischa Reis,
Senior Vice President - Strategy and Corporate Development -
Jean-Claude Kyrillos,
Senior Vice President and President of the KaVo Kerr Business -
Jeffrey Kappler,
Senior Vice President -
Mark Nance,
Senior Vice President, General Counsel, Secretary -
Curt W. Bludworth,
Sr. VP & Chief HR Officer -
Mischa M. Reis,
Sr. VP of Strategy & Corp. Devel. -
Juan Arbona,
Chief Compliance Officer -
John C. Moten,
VP of Investor Relations -
Kari-Lyn Moore,
VP & Chief Accounting Officer -
Robert Befidi,
President, Diagnostics -
Paul A Keel,
Chief Executive Officer -
Corp /De/ Danaher,
10% owner -
William K Daniel,
Director -
Hans Geiselhoeringer,
SENIOR VICE PRESIDENT -
Eric Conley,
SVP, Orthodontics -
Barbara B. Hulit,
Director -
Stephen Keller,
Principal Financial Officer -
Faez C Kaabi,
Chief Accounting Officer -
Eric D. Hammes,
Chief Financial Officer